Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer
Related Experiment Video
Updated: May 26, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
1Department of Urology, The Fourth Affiliated Hospital of Nantong Medical College, Yancheng City No 1 People's Hospital, Nanjing, Jiangsu, PR China.
Abstract:
Dysregulation of microRNA metabolism has been observed in a variety of human cancers. In this study, we evaluated the expression of the enzymes of the machinery Dicer, Drosha and DGCR8, in transitional cell carcinomas (TCCs) of the urinary bladder. The expression of Dicer, Drosha and DGCR8 was analyzed using semi-quantitative RT-PCR in clinical specimens from normal bladder mucosa, TCCs and their normal adjacent tissues (NATs). Immunohistochemistry was performed to compare the expression of Dicer in normal, TCCs and NATs. Our study demonstrated that Dicer mRNA levels in TCCs were significantly lower compared to normal samples and NAT samples. The immunohistochemistry results revealed that Dicer protein levels in TCCs were significantly downregulated compared to normal bladder mucosa and NATs. Our data demonstrated that Dicer is significantly downregulated in TCCs compared to paired NAT samples and normal samples, suggesting that reduced expression of Dicer may play an important role in bladder cancer.
Insights
Dicer enzyme expression is significantly reduced in bladder cancer tissues compared to normal bladder cells. This downregulation of Dicer suggests its potential role in the development of transitional cell carcinomas (TCCs).
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNA (miRNA) metabolism is crucial for cellular function and its dysregulation is linked to various human cancers.
- The enzymes Dicer, Drosha, and DiGeorge syndrome critical region gene 8 (DGCR8) are key players in miRNA biogenesis.
- Altered expression of these enzymes has been implicated in cancer development.
Purpose of the Study:
- To investigate the expression levels of Dicer, Drosha, and DGCR8 in transitional cell carcinomas (TCCs) of the urinary bladder.
- To determine if the expression of these miRNA processing enzymes is altered in bladder cancer tissues compared to normal bladder mucosa and adjacent normal tissues (NATs).
Main Methods:
- Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) was used to analyze mRNA levels of Dicer, Drosha, and DGCR8.
- Immunohistochemistry was employed to assess Dicer protein expression.
- Clinical specimens including normal bladder mucosa, TCCs, and NATs were utilized.
Main Results:
- Dicer mRNA levels were significantly lower in TCCs compared to both normal bladder mucosa and NATs.
- Dicer protein levels were also significantly downregulated in TCCs relative to normal bladder mucosa and NATs.
- No significant changes were reported for Drosha and DGCR8 in this abstract.
Conclusions:
- Dicer is significantly downregulated in transitional cell carcinomas of the urinary bladder at both mRNA and protein levels.
- Reduced Dicer expression may play a critical role in the pathogenesis of bladder cancer.
- These findings highlight Dicer as a potential biomarker or therapeutic target in bladder cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Experimental RNAi
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
piRNA - Piwi-interacting RNAs

